PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pathophysiology, Institute of Physiology and Pathophysiology, Medical Faculty, Johannes Kepler University Linz, Krankenhausstrasse 5, 4020, Linz, Austria.\', \'Institute for Analysis and Scientific Computing, TU Vienna, Vienna, Austria.\', \'Cardiac Surgery Research Laboratory, Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.\', \'Genspeed Biotech GmbH, Rainbach, Austria.\', \'Division of Pathophysiology, Institute of Physiology and Pathophysiology, Medical Faculty, Johannes Kepler University Linz, Krankenhausstrasse 5, 4020, Linz, Austria. christian.wechselberger@jku.at.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00216-022-03966-z
?:doi
?:hasPublicationType
?:journal
  • Analytical and bioanalytical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 35229172
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 142
is ?:relation_isRelatedTo_publication of
?:title
  • Low-entry-barrier point-of-care testing of anti-SARS-CoV-2 IgG in the population of Upper Austria from December 2020 until April 2021-a feasible surveillance strategy for post-pandemic monitoring?
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all